Nanocurcumin Attenuates Doxorubicin‐Induced Cardiotoxicity by Activating the Wnt/β‐Catenin/GSK‐3β Signaling Axis in Wistar Rats
Journal of Biochemical and Molecular Toxicology · 2026-11 · 40 (11)
DOI: 10.1002/jbt.71158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 04.11.2026. Verfasst von Noha A Alshuwayer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Doxorubicin, Glycogen Synthase Kinase 3 beta, Wnt Signaling Pathway, Cardiotoxicity. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ongoing Research Funding program, King Saud University, Riyadh, Saudi Arabia.
Abstract (Originalsprache)
Doxorubicin (DOX)–induced cardiotoxicity remains a major therapeutic limitation, emerging at the intersection of oxidative stress, mitochondrial impairment, and disruption of survival signaling pathways. The Wnt/β‑catenin–GSK‑3β pathway is an essential regulator of cardiomyocyte survival. To assess the cardioprotective potential of nanocurcumin (N‐Cur) in this condition, twenty‐four Wistar rats were divided into four groups (N‐Cur; 80 mg/kg, oral) was given for 2 weeks, while DOX was administered on day seven as a single dose. N‐Cur treatment significantly standardized DOX‑induced elevations in cTnI and CK‑MB, restored cardiac antioxidants (GSH, SOD), decreased MDA levels with p ≤ 0.01, significantly restored Nrf2, and reduced pro‑inflammatory mediators (TNF‑α, IL‑6, NF‑κB‑p65) ( p < 0.001), thereby augmenting its twin roles as a potent anti‐inflammatory and antioxidant agent. The histopathological changes and inflammatory infiltration caused by DOX were significantly diminished following N‐Cur treatment. Further, DOX inhibited Wnt/β‑catenin signaling and increased GSK‑3β expression, whereas N‐Cur reversed these changes in immunohistochemistry studies. Collectively, these findings indicate that N‐Cur provides significant cardiomyocyte protection and efficiently modifies the Wnt/β‑catenin–GSK‑3β axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
ORCID-Profile: Noha A Alshuwayer, Qamraa H Alqahtani, Abdulaziz Siyal, Iman H Hasan
Förderung
- Ongoing Research Funding program
- King Saud University, Riyadh, Saudi Arabia
Zitieren
APA
Alshuwayer, N. A., Alqahtani, Q. H., Hussein, M. H., Mohammed, R., Siyal, A., & Hasan, I. H. (2026). Nanocurcumin Attenuates Doxorubicin‐Induced Cardiotoxicity by Activating the Wnt/β‐Catenin/GSK‐3β Signaling Axis in Wistar Rats. Journal of Biochemical and Molecular Toxicology, 40(11). https://doi.org/10.1002/jbt.71158
Vancouver
Alshuwayer NA, Alqahtani QH, Hussein MH, Mohammed R, Siyal A, Hasan IH. Nanocurcumin Attenuates Doxorubicin‐Induced Cardiotoxicity by Activating the Wnt/β‐Catenin/GSK‐3β Signaling Axis in Wistar Rats. Journal of Biochemical and Molecular Toxicology. 2026;40(11). doi:10.1002/jbt.71158
BibTeX
@article{Alshuwayer2026,
author = {Alshuwayer, Noha A and Alqahtani, Qamraa H and Hussein, Marwa H and Mohammed, Raeesa and Siyal, Abdulaziz and Hasan, Iman H},
title = {Nanocurcumin Attenuates Doxorubicin‐Induced Cardiotoxicity by Activating the Wnt/β‐Catenin/GSK‐3β Signaling Axis in Wistar Rats},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {11},
doi = {10.1002/jbt.71158}
}
EUVIMED